Pomerantz Law Firm Investigates Possible Securities Fraud at Sleep Number Corporation
On June 11, 2026, Pomerantz LLP announced its investigation into Sleep Number Corporation (NASDAQ: SNBR), focusing on claims made by investors regarding potential securities fraud. Stakeholders concerned about their investments in Sleep Number are urged to contact Danielle Peyton at the firm. This inquiry comes in light of alarming financial results reported by the company, including a significant drop in earnings per share and an overall revenue decline.
The backdrop of this investigation is the company's financial performance reported on May 12, 2026, where Sleep Number revealed a GAAP earnings per share of -$2.19. This figure was notably below analysts' expectations by $1.72. Additionally, the revenue announced was $318.99 million, missing expectation by $1.73 million and reflecting an 18.9% decline from the previous year. In a surprising move, Sleep Number also decided to suspend its financial guidance, citing its engagement with Guggenheim Securities for strategic and financing assessments. This prompted a sharp decline in the stock price, which dropped by 22.45%, settling at $1.90 per share by the close of trading on the same day.
Sleep Number Corporation, known for producing adjustable beds, has been under scrutiny for its operational and financial practices. Pomerantz LLP, recognized for its expertise in corporate litigation, particularly in class actions around securities, is now determining whether the company's leadership engaged in unlawful practices that could harm the investors.
The backdrop of this investigation is the company's financial performance reported on May 12, 2026, where Sleep Number revealed a GAAP earnings per share of -$2.19. This figure was notably below analysts' expectations by $1.72. Additionally, the revenue announced was $318.99 million, missing expectation by $1.73 million and reflecting an 18.9% decline from the previous year. In a surprising move, Sleep Number also decided to suspend its financial guidance, citing its engagement with Guggenheim Securities for strategic and financing assessments. This prompted a sharp decline in the stock price, which dropped by 22.45%, settling at $1.90 per share by the close of trading on the same day.
Sleep Number Corporation, known for producing adjustable beds, has been under scrutiny for its operational and financial practices. Pomerantz LLP, recognized for its expertise in corporate litigation, particularly in class actions around securities, is now determining whether the company's leadership engaged in unlawful practices that could harm the investors.
Topics Financial Services & Investing）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.